Harry L. Leider - 28 Jun 2023 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Executive Officer, Director
Signature
/s/ Harry L. Leider
Issuer symbol
OCEL
Transactions as of
28 Jun 2023
Net transactions value
+$59,396
Form type
4
Filing time
30 Jun 2023, 16:05:14 UTC
Previous filing
09 Jun 2023
Next filing
20 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Purchase $54,396 +549,450 $0.0990 549,450 28 Jun 2023 See footnote F1
transaction OCEL Common Stock Purchase $5,000 +500,000 +91% $0.0100 1,049,450 29 Jun 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.